{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hypercalcaemia/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"dc0291c2-c628-503e-a7f7-7f3fa1362b62","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 3d073680-14c5-4754-a58e-26259b5235fa --><h2>When should I suspect hypercalcaemia?</h2><!-- end field 3d073680-14c5-4754-a58e-26259b5235fa -->","summary":"","htmlStringContent":"<!-- begin item c1266f19-c3ea-43c4-b8c8-b278b9a7d76f --><!-- begin field ec98bc44-96dc-44ec-9e24-52f27ec0af46 --><p><strong>Hypercalcaemia is most commonly detected on the basis of <a class=\"topic-reference internal-reference\" href=\"/topics/hypercalcaemia/diagnosis/confirmation/\">blood test results</a> in the UK, and <a class=\"topic-reference internal-reference\" href=\"/topics/hypercalcaemia/background-information/definition/\">mild</a> chronic hypercalcaemia is usually asymptomatic. Consider a diagnosis of hypercalcaemia if:</strong></p><ul><li><strong>There is an incidental finding of a corrected serum calcium concentration of 2.6 mmol/L or higher on blood testing.</strong></li><li><strong>There are suggestive clinical features (which are often non-specific and relate to the severity and rate of onset of hypercalcaemia):</strong><ul><li>Skeletal<ul><li>Bone pain, skeletal deformities.</li><li>Osteoporosis, fractures associated with underlying bone disorders (fragility fractures in hyperparathyroidism, or pathological fractures in malignancy). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/osteoporosis-prevention-of-fragility-fractures/\">Osteoporosis - prevention of fragility fractures</a> for more information.</li></ul></li><li>Neuromuscular and neuropsychiatric<ul><li>Drowsiness, delirium, coma. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/delirium/\">Delirium</a> for more information.</li><li>Fatigue, lethargy, muscle weakness, insomnia. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/tiredness-fatigue-in-adults/\">Tiredness/fatigue in adults</a> and <a class=\"topic-reference external-reference\" href=\"/topics/insomnia/\">Insomnia</a> for more information.</li><li>Impaired concentration and memory, confusion. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/\">Dementia</a> for more information.</li><li>Depression, anxiety, irritability, psychosis. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/psychosis-schizophrenia/\">Psychosis and schizophrenia</a> for more information.</li><li>Neurological signs (for example upper motor neurone deficits, hypotonia, hyporeflexia, and ataxia).</li></ul></li><li>Gastrointestinal<ul><li>Nausea, vomiting, anorexia, weight loss.</li><li>Constipation, abdominal pain. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/constipation/\">Constipation</a> for more information.</li><li>Peptic ulcer, pancreatitis (both rare). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/\">Dyspepsia - proven peptic ulcer</a> and <a class=\"topic-reference external-reference\" href=\"/topics/pancreatitis-acute/\">Pancreatitis - acute</a> for more information.</li></ul></li><li>Renal<ul><li>Renal colic due to renal stones (nephrolithiasis). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/renal-or-ureteric-colic-acute/\">Renal or ureteric colic - acute</a> for more information.</li><li>Thirst, polyuria, polydipsia, nocturia, and dehydration (due to nephrogenic diabetes insipidus).</li><li>Renal impairment (due to nephrocalcinosis and/or obstructive uropathy). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a> for more information.</li></ul></li><li>Cardiovascular<ul><li>Hypertension. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypertension-not-diabetic/\">Hypertension - not diabetic</a> for more information.</li><li>Shortened QT interval; prolonged PR interval on electrocardiogram (ECG).</li><li>Cardiac arrhythmias such as ventricular fibrillation (rare).</li></ul></li><li>Other<ul><li>Flushing, itching, band keratopathy (rare). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/itch-widespread/\">Itch - widespread</a> for more information.</li></ul></li></ul></li></ul><!-- end field ec98bc44-96dc-44ec-9e24-52f27ec0af46 --><!-- end item c1266f19-c3ea-43c4-b8c8-b278b9a7d76f -->","topic":{"id":"c0ab4dd9-cccf-54af-a952-765aa048de1d","topicId":"897bf773-43ef-4092-a798-d9eb4cbcb9cc","topicName":"Hypercalcaemia","slug":"hypercalcaemia","lastRevised":"Last revised in August 2019","chapters":[{"id":"dfffab44-62c8-5590-8bad-e41f249a89e7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"fbfb541d-eae2-5916-af42-b77d9c9ab401","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3c7aba33-da1a-580a-b896-fb6026eb2ad8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"61d715de-b85d-534b-8c6f-0cf5f59814c2","slug":"changes","fullItemName":"Changes"},{"id":"48c69505-e62a-5332-a3ad-fd44bb64bd34","slug":"update","fullItemName":"Update"}]},{"id":"0105d032-866a-57c0-8c83-2f54f2b7b491","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"989b5402-77d7-5cd9-86a7-979019eba917","slug":"goals","fullItemName":"Goals"},{"id":"5d8d7c84-01cb-59e9-a02e-489cb32e799e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7c39bf4-b50f-51f7-ad27-49c431acf456","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb69f34-e184-554d-a518-e9d59c4f95de","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d7060151-5501-51fc-b393-844af2c2ca54","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7d4d8cad-82f7-5bb5-8c59-b47873b845b2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4408b725-f01f-596c-b319-5ef7dd246c3c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"28f41cc2-0513-5841-9fa6-1a59bb557452","slug":"definition","fullItemName":"Definition"},{"id":"b1dd3a7e-6be5-523b-a2c5-c41f9b364798","slug":"causes","fullItemName":"Causes"},{"id":"048198e1-607a-55c4-9d7d-a63135379c28","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3c5e2134-d0b1-5804-bc33-86db97dfc33b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"62c64451-7e13-5be6-b868-01f8198a13ac","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dc0291c2-c628-503e-a7f7-7f3fa1362b62","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c5771a8e-2f1e-53ad-a2fc-322152fc3a3e","slug":"confirmation","fullItemName":"Confirmation"},{"id":"44ef7f17-c907-5252-8027-300e87635dc4","slug":"assessment","fullItemName":"Assessment"}]},{"id":"d005c3ba-c691-53c3-b23c-1c70928fb05d","fullItemName":"Management","slug":"management","subChapters":[{"id":"c604ea66-1be5-51cc-b014-9af770bbc709","slug":"unconfirmed-cause","fullItemName":"Scenario: Unconfirmed cause"},{"id":"4863d234-7059-57aa-b9cc-a51e3a1f3424","slug":"known-malignancy","fullItemName":"Scenario: Known malignancy"},{"id":"fb65182a-1069-5bbd-9c43-a547a8632cec","slug":"follow-up-in-primary-care","fullItemName":"Scenario: Follow-up in primary care"}]},{"id":"4017390d-3b38-5741-8d16-22624da35f3d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"2ec3d6b5-1818-5b5f-af66-bd097d709bf2","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"847bb207-2cb8-5e5f-b3e8-ee87440a71cd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"47a9d106-98da-5683-9641-88d123a8d071","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a8225b5a-40b4-53e5-9095-0953daa376fa","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c60f947f-6176-53b3-9484-54b966632a77","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b6a6af13-45f8-5258-a611-6d8306bbe251","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f68489fb-5d5f-5342-94a0-3979f632012b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"62c64451-7e13-5be6-b868-01f8198a13ac","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"ede565e7-134a-58eb-b041-a7202dd56aa4","slug":"basis-for-recommendation-2ac","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field d76a8722-0d9c-4997-a070-656f549fd048 --><h3>Basis for recommendation</h3><!-- end field d76a8722-0d9c-4997-a070-656f549fd048 -->","summary":null,"htmlStringContent":"<!-- begin item 2ac16ef1-3fd4-4f27-b96c-5a4945c85b73 --><!-- begin field 98c49b91-c054-4f6b-9027-f0c3035f6626 --><p>The recommendations on when to suspect hypercalcaemia are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Hyperparathyroidism (primary): diagnosis, assessment and initial management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">NICE, 2019</a>], the international consensus document <em>Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Bilezikian et al, 2014</a>], the Society for Endocrinology guideline <em>Emergency management of acute hypercalcaemia in adult patients</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Walsh, 2016</a>], and expert opinion in review articles on primary care testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Smellie et al, 2008</a>], on hypercalcaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Minisola, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Turner, 2017</a>], on parathyroid disorders [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Pallan et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Michels, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Bilezikian, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Insogna, 2018</a>], on hypercalcaemia of malignancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Clines, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Zagzag, 2018</a>], and in the palliative care textbook <em>Symptom management in advanced cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Twycross et al, 2009</a>].</p><ul><li>The information that hypercalaemia is most commonly detected incidentally on the basis of blood test results is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Pallan et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Michels, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Turner, 2017</a>].<ul><li>Primary hyperparathyroidism is typically asymptomatic when it is identified [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Bilezikian, 2018</a>].</li><li>In developed countries, about 20% of people with primary hyperparathyroidism present with symptoms, and the remainder are asymptomatic at presentation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Pallan et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Insogna, 2018</a>].</li></ul></li><li>The information that clinical features of hypercalcaemia may be non-specific and are related to the severity and rate of onset of hypercalcaemia is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">NICE, 2019</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Clines, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Pallan et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Michels, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Zagzag, 2018</a>].<ul><li>Intracellular calcium is involved in cell signalling, neural transmission, muscle contraction, enzyme function, hormone secretion, glucogen metabolism, and cell division, and may therefore present with multiple symptoms and signs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>].</li><li>Malignancy-associated hypercalcaemia is often of rapid onset and presents with symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Clines, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>].</li></ul></li><li>The recommendation to consider a diagnosis of hypercalcaemia if there is an incidental finding of a corrected serum calcium concentration of 2.6 mmol/L or higher on blood testing, is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">NICE, 2019</a>].<ul><li>The recommendation to ensure the serum calcium concentration is adjusted ('corrected') for the serum albumin concentration is based on the fact that about 45% of calcium in blood is bound to plasma proteins, particularly albumin. If serum protein concentrations fluctuate, total serum calcium levels may also vary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Smellie et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Meng, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypercalcaemia/references/\">Minisola, 2015</a>].</li></ul></li></ul><!-- end field 98c49b91-c054-4f6b-9027-f0c3035f6626 --><!-- end item 2ac16ef1-3fd4-4f27-b96c-5a4945c85b73 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}